Volume 272, Number 27, Issue of July 4, 1997 pp. 16838-16844
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Role of Heparan Sulfate Proteoglycans in the Uptake and Degradation of Tissue Factor Pathway Inhibitor-Coagulation Factor Xa Complexes

(Received for publication, October 7, 1996, and in revised form, February 19, 1997)

Guyu Ho , George J. Broze Jr.^¶ and Alan L. Schwartz

From the  Departments of Pediatrics, Molecular Biology and Pharmacology, and ^¶ Medicine, Washington University School of Medicine and Division of Hematology, Jewish Hospital of St. Louis, St. Louis, Missouri 63110

Tissue factor pathway inhibitor (TFPI) is a potent inhibitor of blood coagulation factor Xa (fXa) and factor VIIa. We have recently shown that fXa binding stimulates the uptake and degradation of cell surface-bound ¹²⁵I-TFPI (Ho, G., Toomey, J. R., Broze, G. J., Jr., and Schwartz, A. L. (1996) J. Biol. Chem. 271, 9497-9502). In the present study we examined the role of cell surface glycosaminoglycans (GAGs) in this process. Removal of cell surface GAG chains by treatment of cells with heparinase or heparitinase but not chondroitinase markedly reduced fXa-stimulated ¹²⁵I-TFPI uptake and degradation. Inhibition of GAG sulfation by growth of cells in chlorate-containing medium similarly decreased fXa-stimulated ¹²⁵I-TFPI degradation. These results suggest that heparan sulfate proteoglycans (HSPGs) are required for the uptake and degradation of ¹²⁵I-TFPI·fXa complexes. Chemical cross-linking/immunoprecipitation analyses revealed that ¹²⁵I-TFPI was directly associated with HSPGs on the cell surface and that fXa binding increased the amount of ¹²⁵I-TFPI bound. Of the several cell lines evaluated, bend endothelial cells demonstrated the greatest fXa stimulation of ¹²⁵I-TFPI uptake and degradation. Cross-linking/immunoprecipitation analyses on bend cells also revealed that HSPGs were specifically associated with TFPI and fXa. These data suggest that HSPGs may directly act as the uptake and degradation receptor for TFPI·fXa complexes.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Y. Banz, O. M. Hess, S. C. Robson, D. Mettler, P. Meier, A. Haeberli, E. Csizmadia, E. Y. Korchagina, N. V. Bovin, and R. Rieben Locally targeted cytoprotection with dextran sulfate attenuates experimental porcine myocardial ischaemia/reperfusion injury Eur. Heart J., November 1, 2005; 26(21): 2334 - 2343. [Abstract] [Full Text] [PDF]

				J. Ahamed, M. Belting, and W. Ruf Regulation of tissue factor-induced signaling by endogenous and recombinant tissue factor pathway inhibitor 1 Blood, March 15, 2005; 105(6): 2384 - 2391. [Abstract] [Full Text] [PDF]

				S. Ropero, F. Setien, J. Espada, M. F. Fraga, M. Herranz, J. Asp, M. S. Benassi, A. Franchi, A. Patino, L. S. Ward, et al. Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells Hum. Mol. Genet., November 15, 2004; 13(22): 2753 - 2765. [Abstract] [Full Text] [PDF]

				S. Butenas, T. Orfeo, M. T. Gissel, K. E. Brummel, and K. G. Mann The Significance of Circulating Factor IXa in Blood J. Biol. Chem., May 28, 2004; 279(22): 22875 - 22882. [Abstract] [Full Text] [PDF]

				A. M. Di Biase, A. Tinari, A. Pietrantoni, G. Antonini, P. Valenti, M. P. Conte, and F. Superti Effect of bovine lactoferricin on enteropathogenic Yersinia adhesion and invasion in HEp-2 cells J. Med. Microbiol., May 1, 2004; 53(5): 407 - 412. [Abstract] [Full Text] [PDF]

				J. Reiland, R. D. Sanderson, M. Waguespack, S. A. Barker, R. Long, D. D. Carson, and D. Marchetti Heparanase Degrades Syndecan-1 and Perlecan Heparan Sulfate: FUNCTIONAL IMPLICATIONS FOR TUMOR CELL INVASION J. Biol. Chem., February 27, 2004; 279(9): 8047 - 8055. [Abstract] [Full Text] [PDF]

				J. Zhang, O. Piro, L. Lu, and G. J. Broze Jr Glycosyl Phosphatidylinositol Anchorage of Tissue Factor Pathway Inhibitor Circulation, August 5, 2003; 108(5): 623 - 627. [Abstract] [Full Text] [PDF]

				G. Ho, M. Narita, G. J. Broze Jr, and A. L. Schwartz Recombinant full-length tissue factor pathway inhibitor fails to bind to the cell surface: implications for catabolism in vitro and in vivo Blood, March 15, 2000; 95(6): 1973 - 1978. [Abstract] [Full Text] [PDF]

				I. Ott, Y. Miyagi, K. Miyazaki, M. J. Heeb, B. M. Mueller, L. V. M. Rao, and W. Ruf Reversible Regulation of Tissue Factor-Induced Coagulation by Glycosyl Phosphatidylinositol-Anchored Tissue Factor Pathway Inhibitor Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 874 - 882. [Abstract] [Full Text] [PDF]

				M. Toyoshima and M. Nakajima Human Heparanase. PURIFICATION, CHARACTERIZATION, CLONING, AND EXPRESSION J. Biol. Chem., August 20, 1999; 274(34): 24153 - 24160. [Abstract] [Full Text] [PDF]